Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Signs MOU to Mine High Grade Zone 2 at Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gap Inc V.GAP


Primary Symbol: GAP

Consumer Cyclical
The Gap, Inc. is a specialty apparel company in America. The Company offers apparel, accessories and personal care products for women, men and children. Its Old Navy, Gap, Banana Republic, and Athleta brands offer clothing, accessories and lifestyle products for men, women and children. It is an omni-channel retailer, with sales to customers both in stores and online, through Company-operated and franchise stores, websites, and third-party arrangements. Its omni-channel services, including buying online pick-up in store, order-in-store, find-in-store, and ship-from-store, as well as enhanced mobile-enabled experiences, are tailored across its collection of brands. Gap includes adult apparel and accessories, GapKids, babyGap, Gap Maternity, GapBody, and GapFit collections. Banana Republic is a premium lifestyle retailer celebrating exploration and self-expression through timeless quality, versatile fabrics, and exceptionally made womenswear, menswear, and home designs.


NYSE:GAP - Post by User

Gap Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by andyroon Sep 28, 2009 2:32pm
292 Views
Post# 16344438

Another article from Axcess today

Another article from Axcess todayMonday, 28 September 2009
Print ArticlePrint Article Bookmark ArticleBookmark page Email ArticleEmail Article

Investors see value in PharmaGap. Await cancer test results.



By Armando Duke

(AXcess News) Houston - Investors were lining up in PharmaGap (TSX-V: GAP; OTC: PHRGF.PK) over the past several weeks in advance of testing results of its drug compound PhG-alpha-1 for the treatment of cancer which is in preclinical development. Tests are being conducted both in Canada and the US.

Ottawa-based PharmaGap announced in early May 2009 that the National Cancer Institute in Bethesda Maryland was conducting tumor cell panel tests on 60 human cancer cell lines. Additional testing on the effect of PhG-alpha-1 on cancer cell growth rate, mobility and invasion characteristics, using a panel of nine ovarian cancer cell lines is also being conducted at the Ottawa Hospital Research Institute (OHRI), which was announced the day before the NCI tests. Of the OHRI cell lines being tested, two are also included in the 60 cell line panel used in the NCI tests.

Robert McInnis, President of PharmaGap, had revealed in that May announcement that the Company had contracted with CS Bio of Menlo Park California to produce its cancer drug, PhG-alpha-1, a key step in meeting FDA Health Canada guidelines in approving drugs for human testing. McInnis was quoted in that release as saying, "We are also very pleased to have developed a relationship with CS Bio as a commercial partner for larger scale drug production going forward."

PharmaGap was featured in a syndicated AXcess News story on June 19, having announced later that day the completion of an $860,000 private placement. In that news it was noted that PharmaGap was one of only five companies Canada's National Research Council (NRC) had invested in, a practice AXcess News criticized the Obama administration over for not considering similar programs as part of its healthcare reform plan.

The following week, PharmaGap announced a second round of financing with NRC to the tune of $215,000, placing the government-backed National Research Council's stake in the biotechnology company at 3.2 percent.

At the time of that announcement, McInnis was quoted as saying, "We are pleased that the NRC recognizes the value potential in our Company, and appreciate its continued support as a valued partner."


https://www.axcessnews.com/index.php/articles/show/id/18750
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested